{
    "2019-05-05": [
        [
            {
                "time": "2019-05-05",
                "original_text": "华金证券晚间资讯（20190505）",
                "features": {
                    "keywords": [
                        "华金证券",
                        "晚间资讯"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05",
                "original_text": "板块分化后的投资策略 ——兴证医药2019年5月投资月报",
                "features": {
                    "keywords": [
                        "板块分化",
                        "投资策略",
                        "兴证医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05",
                "original_text": "『医药头条君』抗逆转录病毒治疗下HIV病毒感染零风险",
                "features": {
                    "keywords": [
                        "抗逆转录病毒",
                        "HIV",
                        "零风险"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05",
                "original_text": "【国盛医药张金洋团队】年报季报验证医药从野蛮扩张到结构优化，继续推荐医药流通",
                "features": {
                    "keywords": [
                        "年报季报",
                        "结构优化",
                        "医药流通"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05",
                "original_text": "11家药企研发投入破10亿！4家超过20亿",
                "features": {
                    "keywords": [
                        "药企",
                        "研发投入",
                        "10亿",
                        "20亿"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}